Definitive Healthcare (NASDAQ:DH) Issues FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.340-0.350 for the period, compared to the consensus estimate of 0.330. The company issued revenue guidance of $250.0 million-$251.0 million, compared to the consensus revenue estimate of $249.2 million. Definitive Healthcare also updated its Q4 guidance to $0.07 EPS.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. JPMorgan Chase & Co. cut shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and decreased their target price for the company from $7.00 to $5.00 in a research report on Wednesday, July 31st. BTIG Research started coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target on the stock. Stifel Nicolaus lowered their price objective on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research report on Wednesday, July 31st. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Friday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Stock Down 1.6 %

Shares of NASDAQ:DH traded down $0.07 during trading hours on Friday, reaching $4.24. The stock had a trading volume of 1,200,343 shares, compared to its average volume of 326,752. The stock has a market capitalization of $500.02 million, a price-to-earnings ratio of -1.22, a P/E/G ratio of 6.27 and a beta of 1.33. The firm’s 50 day moving average is $4.36 and its 200-day moving average is $4.98. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.